Skip to main content

Table 1 Demographics and medical history of LDKT recipients

From: Moon phases and moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation

   Patient groups according to moon phases/moon sign Libra    P-value*
  n (%) a New moon Waxing moon Full moon Waning moon Moon sign Libra  
Demographics
 Number of patients 278 (100.0) 33 (100.0) 111 (100.0) 32 (100.0) 102 (100.0) 17 (100.0)  
 Age (years) b,c 42.0 [7.4 - 74.0] 45.3 [7.6 - 68.8] 40.0 [17.8 - 73.9] 42.1 [7.4 - 69.0] 45.6 [9.3 - 70.3] 35.9 [23.1 - 61.6] 0.213
 Sex (m/f) 192 (69.0)/86 (31.0) 28 (84.8)/5 (15.2) 74 (66.7)/37 (33.3) 23 (71.9)/9 (28.1) 67 (65.7)/35 (34.3) 12 (70.6)/5 (29.4) 0.186
 BMI (kg/m2) c 23.8 [16.4 - 34.8] 24.5 [16.7 - 30.9] 23.9 [16.4 - 33.8] 22.9 [17.2 - 30.9] 23.8 [16.9 - 34.8] 23.9 [17.4 - 28.0] 0.784
Medical history
 Total duration of dialysis (years) b,c 1.96 [0.04 - 10.64] 1.75 [0.04 - 7.32] 2.02 [0.2 - 10.6] 1.8 [0.2 - 7.7] 2.3 [0.04 - 10.5] 2.4 [0.7 - 10.6] 0.606
 Peritoneal dialysis 30 (10.8) 0 (0) 14 (12.6) 3 (9.4) 13 (12.7) 3 (17.6) 0.176
Cause of kidney failure d
 Chronic glomerulonephritis 88 (31.7) 8 (24.2) 32 (28.8) 11 (34.4) 37 (36.3) 6 (35.3) 0.500
 IgA nephritis 24 (8.6) 4 (12.1) 10 (9.0) 2 (6.3) 8 (7.8) 0 (0) 0.840
 Polycystic kidney disease 19 (6.8) 2 (6.1) 8 (7.2) 2 (6.3) 7 (6.9) 3 (17.6) 0.995
 Diabetic nephropathy 13 (4.7) 2 (6.1) 8 (7.2) 1 (3.1) 2 (2.0) 2 (11.8) 0.308
Transplantation history
 one or more KT prior to LDKT 33 (11.9) 3 (9.09) 14 (12.6) 3 (9.4) 13 (12.7) 2 (11.8) 0.915
Follow up
Follow-up after LDKT (years) c 8.2 [0.13 - 15.2] 8.1 [1.9 - 12.6] 7.9 [0.13 - 14.6] 10.4 [0.8 - 15.2] 8.3 [0.6 - 14.2] 6.0 [1.9 - 12.3]  
  1. KT kidney transplantation
  2. LDKT living donor kidney transplantation
  3. * p-values are calculated for moon phases only
  4. avalues are number (percentage) unless indicated otherwise
  5. bdata are presented with respect to the date of LDKT
  6. cvalues are median [range]
  7. dmost common causes